Brimonidine Tartrate contains not less than 99.0% and not more than 101.0% of C15H16BrN5O6, calculated on the dried substance.

共有 1 個藥物證書使用此成份

溴亞胺咪唑酒石酸鹽
Brimonidine Tartrate

• 申請商: 宣泓貿易有限公司
• 適應症: 開放角隅青光眼或高眼壓
• 發證日期: 2021-07-26